Synthesis, characterization and antitumor activity of 2-methyl-9-substituted acridines

Arabian Journal of Chemistry

Volumn 10, Issue , 2017, Pages S956-S963

  Kumar, Rajesh ^a   Sharma, Ankita ^a   Sharma, Sarita ^b   Silakari, Om ^c   Singh, Mandeep ^a   Kaur, Manmeet ^a  

^a Shivalik College of Pharmacy   (India)

^b Global College of Pharmacy   (India)

^c PUNJABI UNIVERSITY   (India)

Author keywords

2 Methylacridine; Antiproliferative activity; Aromatic amines; Cyclization; Intercalation

Indexed keywords

AMINES; AROMATIC COMPOUNDS; CELL CULTURE; CYCLIZATION; CYTOLOGY; CYTOTOXICITY; DISEASES; INTERCALATION; SPECTROSCOPIC ANALYSIS;

2-METHYLACRIDINE; ANTI-PROLIFERATIVE ACTIVITIES; ANTI-TUMOR ACTIVITIES; ANTIPROLIFERATIVE PROPERTIES; AROMATIC AMINES; CANCER CHEMOTHERAPEUTICS; NUCLEOPHILIC SUBSTITUTIONS; SPECTROSCOPIC METHOD;

CELLS;

EID: 84872794012     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2012.12.035     Document Type: Article

References (32)

1. Alberg, A.J., Brock, M.V., Stuart, J.M., Epidemiology of lung cancer: looking to the future. J. Clin. Oncol. 23 (2005), 3175–3185.
2. Aly, E.L., Abadi, A.H., Synthesis and antitubercular acivity of 6-chloro(unsubsituted)-2-methoxy-9-subsituted acridines derivatives. Arch. Pharm. Res. 27 (2004), 713–719.
3. Antonini, I., Santoni, G., Lucciarni, R., Amantini, C., Sparpani, S., Magnano, A., Synthesis & biological evaluation of new assymetrical bisintercalators as potent antitumour drugs. J. Med. Chem. 49 (2006), 7198–7207.
4. Bacherikov, V.A., Chang, J.Y., Lin, Y.W., Synthesis and antitumour activity of 5-(9-acridinylamino) anisidine derivative. Biorg. Med. Chem. 13 (2005), 6513–6520.
5. Belmont, P., Bosson, J., Godet, T., Tiano, M., Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now?. Anticancer Agents Med. Chem. 7 (2007), 139–169.
6. Belmont, P., Dorange, I., Acridine/acridone: a simple scaffold with a wide range of application in oncology. Exp. Opin. Ther. Patents 18 (2008), 1211–1222.
7. Boyer, G., Lormier, T., Galy, J.P., Llamas-Saiz, A.L., Foces-Foces, C., Fierros, M., Elguero, J., Virgili, A., X-ray crystallography at 170K of racemic 2,2′-dimethoxy-9,9′-biacridine and 1H NMR study of 2,2′-diacetoxy-9,9′-biacridine. Molecules 4 (1999), 104–121.
8. Chang, J.Y., Lin, C.F., Pan, W.Y., Bacherikov, V., Chou, T.C., Chen, C.H., Dong, H., Cheng, S.Y., Tasi, T.J., Lin, Y.W., Chen, K.T., Chen, L.T., Su, T.L., New analogs of AHMA as potential antitumor agents: synthesis and biological activity. Bioorg. Med. Chem. 11 (2003), 4959–4969.
9. Cohen, A.J., Ross, A.H., Ostro, B., The global burden of disease due to outdoor air pollution. J. Toxicol. Environ. Health 68 (2005), 1301–1307.
10. Cookson, J.C., Heald, R.A., Stevens, M.F.G., Antitumour polycyclic acridines. 17. Synthesis and pharmaceutical profile of pentacyclic acridinium salts designed to destabilize telomeric integrity. J. Med. Chem. 48 (2005), 7198–7207.
11. Demeunynck, M., Antitumour acridines. Exp. Opin. Ther. Pat. 14 (2004), 55–70.
12. Demeunynck, M., Charmantray, F., Martelli, A., Interest of acridine derivatives in the anticancer chemotherapy. Curr. Pharm. Des. 7 (2001), 1703–1724.
13. Denny, W.A., Acridine derivatives as chemotherapeutic agents. Curr. Med. Chem. 9 (2002), 1655–1665.
14. Denny, W.A., Chain, B.F., Atwell, G.J., Hansch, C., Leo, A., Potential antitumour agents. 36. Quantitative relationships between experimental antitumour activity, toxicity and structure for general class of 9-anilinoacridine agents. J. Med. Chem. 25 (1982), 276–313.
15. Dimanche-Boitrel, M.T., Garido, C., Chauffert, B., Kinetic resistance to anticancer agents. Cytotechnology 12 (1993), 347–356.
16. Francis, D., Rita, L., Rapid colorimetric assay for cell growth and survival modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986), 271–277.
17. Gamage, S.A., Tepsiel, N., Wilairat, P., Wajcik, S.J., Figgit, D.P., Ralph, R.K., Denny, W.A., Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug resistant strain of the malaria parasite Plasmodium falciparum. J. Med. Chem. 37 (1994), 1486–1494.
18. Giorgia, C.D., Shimi, K., Boyer, G., Delmas, F., Galy, J.P., Synthesis and antileishmanial activity of 6-mono-subsituted and 3,6-disubsituted acridines obtained by arylation of proflavine. Eur. J. Med. Chem. 42 (2007), 1277–1284.
19. Goodwell, J.R., Basagoiti, F.P., Forsley, B.M., Shi, P.Y., Fergudon, D.M., Identification of compounds with anti-west nile virus activity. J. Med. Chem. 49 (2006), 2127–2137.
20. Guddneppanavar, R., Saluta, G., Kucera, G.L., Bierbach, U., Synthesis, biological activity and DNA damage profile of platinium-threading intercalator conjugates designed to target adenine. J. Med. Chem. 49 (2006), 3204–3214.
21. Hagan, D.J., Gimenez-Arnau, E., Schwalbe, C.H., Stevens, M.F.G., Antitumour polycyclic acridines. Part 1. Synthesis of 7H- pyrido-and 8H-quino-[4,3,2-kl]acridines by Graebe-Ulmann thermolysis of 9-(1,2,3-triazol-1-yl)acridines: application of differential scanning calorimetry to predict optimum cyclisation conditions. J. Chem. Soc. Perkin. Trans. 1 (1997), 2739–2746.
22. Kohn, K.W., Orr, A., Connor, P.M., Synthesis and DNA sequence selectivity of series of mono- & difunctional 9-aminoacridine nitrogen mustards. J. Med. Chem. 37 (1994), 67–72.
23. Kumar, P., Kumar, R., Prasad, D.N., Synthesis and biological evaluation of new 9-aminoacridine-4-carboxamide derivatives as anticancer agents. Arabian J. Chem. 6 (2013), 59–65.
24. Kumar, P., Kumar, R., Prasad, D.N., Synthesis and anticancer study of 9-aminoacridine derivatives. Arabian J. Chem. 6 (2013), 79–85.
25. Michael, S., Gaslonde, T., Tillequin, F., Benzo acronycine derivatives: a novel class of antitumour agents. Eur. J. Med. Chem. 39 (2004), 695–755.
26. Mosmann, T., Rapid colorimeteric assay for cellular growth & survival: application to proliferation & cytotoxicity assay. J. Immunol. Methods 65 (1983), 55–63.
27. Parkin, D.M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics 2002. CA Cancer J. Clin. 55:2 (2005), 74–108.
28. Su, T.L., Chen, C.H., Huang, L.F., Chen, C.H., Basu, M.K., Zhang, X.G., Chou, T.C., Synthesis and structure-activity relationships of potential anticancer agents: alkylcarbamates of 3-(9-acridinylamino)-5-hydroxymethylaniline. J. Med. Chem. 43 (1999), 4741–4748.
29. Su, T.L., Chou, T.C., Kim, J.Y., Huang, J.T., Ciszeuska, G., Ren, W.Y., Otter, G.M., Sirotnak, F.M., Watanabe, K.A., 9-Substituted acridine derivatives with long half-life and potent antitumour activity: synthesis and structure activity relationships. J. Med. Chem. 38 (1995), 3226–3235.
30. Valdes, A.F.C., Acridine & acridones: old & new structure with antimalarial activity. Open Med. Chem. J. 5 (2011), 11–20.
31. Wainwright, M., Acridine-a neglected antibacterial chromophore. J. Antimicrob. Chemo. 47 (2001), 1–13.
32. Yim, S.K., Yun, C.H., Ahn, T., Jung, H.C., Pan, J.G., A continuous spectrophotometric assay for NADPH-cytochrome p450 reductase activity using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. J. Biochem. Mol. Biol. 38:3 (2005), 366–369.